HEADER SIGNALING PROTEIN 13-DEC-05 2DA0 TITLE SOLUTION STRUCTURE OF THE PH DOMAIN OF PIP2-DEPENDENT ARF1 GTPASE- TITLE 2 ACTIVATING PROTEIN FROM HUMAN COMPND MOL_ID: 1; COMPND 2 MOLECULE: 130-KDA PHOSPHATIDYLINOSITOL 4,5-BIPHOSPHATE-DEPENDENT ARF1 COMPND 3 GTPASE-ACTIVATING PROTEIN; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: PH DOMAIN; COMPND 6 SYNONYM: PIP2-DEPENDENT ARF1 GAP, ADP-RIBOSYLATION FACTOR-DIRECTED COMPND 7 GTPASE-ACTIVATING PROTEIN 1, ARF GTPASE-ACTIVATING PROTEIN 1, COMPND 8 DEVELOPMENT AND DIFFERENTIATION-ENHANCING FACTOR 1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ASAP1; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: P050801-06; SOURCE 8 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS KEYWDS PH DOMAIN, ARF GTPASE-ACTIVATING PROTEIN 1, STRUCTURAL GENOMICS, KEYWDS 2 NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL KEYWDS 3 ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, KEYWDS 4 SIGNALING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR H.LI,T.TOMIZAWA,S.KOSHIBA,M.INOUE,T.KIGAWA,S.YOKOYAMA,RIKEN AUTHOR 2 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 3 09-MAR-22 2DA0 1 REMARK SEQADV REVDAT 2 24-FEB-09 2DA0 1 VERSN REVDAT 1 13-JUN-06 2DA0 0 JRNL AUTH H.LI,T.TOMIZAWA,S.KOSHIBA,M.INOUE,T.KIGAWA,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE PH DOMAIN OF PIP2-DEPENDENT ARF1 JRNL TITL 2 GTPASE-ACTIVATING PROTEIN FROM HUMAN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 3.5, CYANA 2.0.17 REMARK 3 AUTHORS : BRUKER (XWINNMR), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DA0 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-DEC-05. REMARK 100 THE DEPOSITION ID IS D_1000025171. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 296 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.18MM PH DOMAIN U-15N,13C; 20MM REMARK 210 D-TRIS-HCL(PH 7.0); 100MM NACL; REMARK 210 1MM D-DTT; 0.02% NAN3; 90% H2O, REMARK 210 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20030801, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.932, CYANA 2.0.17 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION,STRUCTURES WITH REMARK 210 THE LEAST RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 10 37.11 -92.18 REMARK 500 1 SER A 20 168.80 -45.47 REMARK 500 1 PRO A 50 -176.31 -69.79 REMARK 500 1 ASN A 63 157.94 -38.83 REMARK 500 1 GLU A 65 -56.04 -122.19 REMARK 500 1 ASP A 66 83.64 -56.15 REMARK 500 1 HIS A 75 107.61 -46.85 REMARK 500 1 VAL A 95 -70.33 -72.02 REMARK 500 2 SER A 3 127.22 -39.30 REMARK 500 2 ASP A 21 162.56 -46.39 REMARK 500 2 SER A 46 93.55 -35.50 REMARK 500 2 PRO A 50 -176.89 -69.79 REMARK 500 2 ASN A 63 174.54 -47.77 REMARK 500 2 LYS A 67 178.41 -50.85 REMARK 500 2 SER A 69 115.77 -173.27 REMARK 500 2 VAL A 95 -70.94 -71.17 REMARK 500 2 THR A 105 -27.64 -39.97 REMARK 500 2 ALA A 107 139.76 -33.40 REMARK 500 3 SER A 2 158.03 -46.47 REMARK 500 3 SER A 3 42.71 -82.14 REMARK 500 3 ASN A 63 -176.63 -55.24 REMARK 500 3 ALA A 64 -44.07 -131.52 REMARK 500 3 LYS A 68 58.48 -117.29 REMARK 500 3 SER A 113 115.85 -37.74 REMARK 500 4 SER A 20 96.34 -68.99 REMARK 500 4 LYS A 25 96.42 -64.78 REMARK 500 4 HIS A 43 -51.13 -131.67 REMARK 500 4 SER A 46 39.59 -91.10 REMARK 500 4 ARG A 48 -71.33 -119.56 REMARK 500 4 GLN A 49 139.76 -173.71 REMARK 500 4 PRO A 50 -167.04 -69.81 REMARK 500 4 LYS A 68 40.17 34.51 REMARK 500 4 HIS A 75 105.03 -43.23 REMARK 500 4 ASN A 76 39.58 36.17 REMARK 500 4 GLU A 102 -19.88 -48.81 REMARK 500 4 PHE A 108 50.27 38.85 REMARK 500 4 PRO A 111 2.27 -69.80 REMARK 500 5 ILE A 23 -58.76 -126.77 REMARK 500 5 ALA A 44 -73.41 -124.51 REMARK 500 5 ASN A 63 157.05 -46.36 REMARK 500 5 HIS A 75 102.22 -45.12 REMARK 500 5 VAL A 95 -70.53 -71.03 REMARK 500 5 PHE A 108 106.17 -45.29 REMARK 500 6 SER A 6 156.84 -43.37 REMARK 500 6 ASP A 21 149.52 -34.53 REMARK 500 6 LYS A 25 34.23 -84.67 REMARK 500 6 HIS A 43 149.81 -172.70 REMARK 500 6 ALA A 44 48.87 34.21 REMARK 500 6 THR A 45 92.65 -68.12 REMARK 500 6 HIS A 75 103.03 -40.07 REMARK 500 REMARK 500 THIS ENTRY HAS 162 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSK002001223.1 RELATED DB: TARGETDB DBREF 2DA0 A 8 108 UNP Q9ULH1 DDEF1_HUMAN 150 250 SEQADV 2DA0 GLY A 1 UNP Q9ULH1 CLONING ARTIFACT SEQADV 2DA0 SER A 2 UNP Q9ULH1 CLONING ARTIFACT SEQADV 2DA0 SER A 3 UNP Q9ULH1 CLONING ARTIFACT SEQADV 2DA0 GLY A 4 UNP Q9ULH1 CLONING ARTIFACT SEQADV 2DA0 SER A 5 UNP Q9ULH1 CLONING ARTIFACT SEQADV 2DA0 SER A 6 UNP Q9ULH1 CLONING ARTIFACT SEQADV 2DA0 GLY A 7 UNP Q9ULH1 CLONING ARTIFACT SEQADV 2DA0 SER A 109 UNP Q9ULH1 CLONING ARTIFACT SEQADV 2DA0 GLY A 110 UNP Q9ULH1 CLONING ARTIFACT SEQADV 2DA0 PRO A 111 UNP Q9ULH1 CLONING ARTIFACT SEQADV 2DA0 SER A 112 UNP Q9ULH1 CLONING ARTIFACT SEQADV 2DA0 SER A 113 UNP Q9ULH1 CLONING ARTIFACT SEQADV 2DA0 GLY A 114 UNP Q9ULH1 CLONING ARTIFACT SEQRES 1 A 114 GLY SER SER GLY SER SER GLY TYR GLY SER GLU LYS LYS SEQRES 2 A 114 GLY TYR LEU LEU LYS LYS SER ASP GLY ILE ARG LYS VAL SEQRES 3 A 114 TRP GLN ARG ARG LYS CYS SER VAL LYS ASN GLY ILE LEU SEQRES 4 A 114 THR ILE SER HIS ALA THR SER ASN ARG GLN PRO ALA LYS SEQRES 5 A 114 LEU ASN LEU LEU THR CYS GLN VAL LYS PRO ASN ALA GLU SEQRES 6 A 114 ASP LYS LYS SER PHE ASP LEU ILE SER HIS ASN ARG THR SEQRES 7 A 114 TYR HIS PHE GLN ALA GLU ASP GLU GLN ASP TYR VAL ALA SEQRES 8 A 114 TRP ILE SER VAL LEU THR ASN SER LYS GLU GLU ALA LEU SEQRES 9 A 114 THR MET ALA PHE SER GLY PRO SER SER GLY HELIX 1 1 GLU A 86 THR A 105 1 20 SHEET 1 A 7 ALA A 51 ASN A 54 0 SHEET 2 A 7 ILE A 38 ILE A 41 -1 N LEU A 39 O LEU A 53 SHEET 3 A 7 TRP A 27 LYS A 35 -1 N SER A 33 O THR A 40 SHEET 4 A 7 LYS A 12 LYS A 19 -1 N LEU A 16 O ARG A 30 SHEET 5 A 7 ARG A 77 GLN A 82 -1 O GLN A 82 N LEU A 17 SHEET 6 A 7 PHE A 70 SER A 74 -1 N SER A 74 O ARG A 77 SHEET 7 A 7 GLN A 59 PRO A 62 -1 N LYS A 61 O ASP A 71 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1